← Browse by Condition
Medical Condition

dengue

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for dengue sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dengue Clinical Trials

How many clinical trials are currently recruiting for dengue?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for dengue, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for dengue?
dengue research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a dengue clinical trial?
Eligibility criteria for dengue trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Phase 3
1
Top Sponsors
Oxford University Clinical Research Unit, Vietnam 1 trial
National Institute of Allergy and Infectious Diseases (NIAID) 1 trial
Institut Pasteur du Cambodge 1 trial
Butantan Institute 1 trial

Recruiting Clinical Trials

NCT06551844 Phase 2
Recruiting
Adaptive Dengue Antiviral Platform Trial
Enrollment
500 pts
Location
Malaysia, Vietnam
Sponsor
Oxford University Clinical Res...
View Trial →
NCT07706686 Phase 1
Recruiting
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Enrollment
200 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT07358910
Recruiting
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Enrollment
10,000 pts
Location
Cambodia
Sponsor
Institut Pasteur du Cambodge
View Trial →
NCT06891950 Phase 3
Recruiting
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Enrollment
997 pts
Location
Brazil
Sponsor
Butantan Institute
View Trial →

Related Conditions

antiviral drugs (1) healthy volunteers (1) human challenge trial (1) chikungunya (1) zika virus infection (1) japanese encephalitis (1) west nile virus (1) tick borne encephalitis tbe (1) severe fever with thrombocytopenia syndrome (1) nipah virus infection (1) hantavirus infections (1) hepatitis e (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology